Global RNA Sequencing Services Market Outlook 2025-2034: Trends, Innovations, And Future Outlook

The RNA Sequencing Services Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the RNA Sequencing Services Market Size and Projected Growth Rate?
In the recent past, the RNA sequencing services industry has seen a quick expansion in its market size. Predictions show an increase from $3.58 billion in 2024 to a substantial $4 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 11.6%. Factors that have contributed to this growth in the historical period are the escalating demand for personalized medicine, progress in bioinformatics tools, an augmented focus on drug discovery and enhancement, growing utilization of RNA sequencing within agricultural research, and widening implementations of the service in clinical diagnostics.

The market size of RNA sequencing services is anticipated to witness swift expansion in the forthcoming years. The market is projected to surge to a value of $6.13 billion in 2029, progressing with a compound annual growth rate (CAGR) of 11.3%. This projected growth in the forecast tenure can be linked to the advent of single-cell RNA sequencing technologies, the incorporation of artificial intelligence and machine learning in data examination, enlarged research on non-coding RNA biomarkers, escalating demand for transcriptomic examination in immunotherapy research, and an increase in partnerships between the academia and industry for genomic studies. Notable tendencies in the prediction period encompass the adoption of long-read sequencing, the emergence of cloud-based analysis platforms, the demand for RNA splicing examination, and the integration of multi-omics data.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=14991

What Are the Major Segments in the RNA Sequencing Services Market?
The RNA sequencing services market covered in this report is segmented -

1) By Type: Ribosomal RNA (rRNA), Transfer RNA (tRNA), Long non-coding RNA (lncRNA)
2) By Sequencing Method: Next Generation Sequencing Methods, Other Sequencing Methods
3) By Application Area: Research Purposes, Diagnostic Purposes
4) By End Users: Academic And Government Institutes And Research Centers, Hospitals And Clinics, Pharmaceutical And Biotechnology Companies, Other End Users

Subsegments:
1) By Ribosomal RNA (rRNA): Total RRNA Sequencing, RRNA Depletion
2) By Transfer RNA (tRNA): TRNA Profiling, TRNA Sequencing
3) By Long Non-Coding RNA (lncRNA): lncRNA Profiling, lncRNA Sequencing

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=14991&type=smp

What Are The Driving RNA Sequencing Services Market Evolution?
The upward trend in demand for personalized medicine is making a significant impact on the expansion of the RNA sequencing services market. Customized medicine involves modifying healthcare treatments to better suit individual traits such as genetics or lifestyle, with the goal of maximizing efficacy and reducing negative side effects. The rising popularity of personalized medicine can be attributed to its ability to offer improved treatment, advancements in genomics, the growing complexity of diseases, and regulatory backing. RNA sequencing services play a crucial role in recognizing disease subtypes, finding biomarkers, pinpointing therapeutic targets, forecasting therapy outcomes, and monitoring disease progression and the results of treatments. Personalized medicine methodologies utilize RNA sequencing technologies to produce bespoke and potent medicines that cater to the unique molecular traits of each patient. For instance, the Personalized Medicine Coalition, a non-profit organization based in the US, reported in February 2024 that the FDA (Food and Drug Administration) had given approval to 16 new personalized therapies for patients suffering from rare diseases in 2023, a significant increase from the six approved in 2022. Included in the newly approved personalized treatments for 2023 were seven cancer drugs and three for other diseases and conditions. Therefore, the escalating demand for personalized medicine is propelling the advancement of the RNA sequencing services market.

Which Firms Dominate The RNA Sequencing Services Market Segments?
Major companies operating in the RNA sequencing services market are Thermo Fisher Scientific Inc., Feng Chi Biotech Corp., Illumina Inc., Qiagen NV, BGI Genomics Co. Ltd., Azenta Inc., Abcam Limited, Novogene Co. Ltd., Genewiz Inc., Diagenode LLC, CD Genomics, CeGaT GmbH, Lexogen GmbH, BaseClear BV, Active Motif Inc., Microsynth AG, RayBiotech Inc., Genomax Technologies Pte. Ltd., Phalanx Biotech Group Inc., Creative Biogene, SeqMatic LLC, Genohub Inc., Otogenetics, LC Sciences, Admera Health, Arraystar Inc., IGA Technology, Yaazh Xenomics

What Trends Are Driving Growth in The RNA Sequencing Services Market?
Key players in the RNA sequencing services market are turning to automation to minimize potential human errors, with a key focus on next-generation sequencing (NGS) assays to improve efficiency and precision in both data collection and analysis. The RNA next-generation sequencing (RNA-seq) assay, a potent instrument in molecular biology and genomics, is used for analyzing the transcriptome of a given biological specimen. In a case, from June 2023, US-based precision medicine technology firm Tempus, announced the arrival of their innovativeTemprus XR standalone RNA next-generation sequencing assay, primarily designed for solid tumors. This breakthrough assay provides a thorough analysis of the complete transcriptome, underlining clinically consequential fusions in over 100 targeted genes, and altered splicing for MET Exon 14 and EGFRvIII. Tempus, understanding the importance of RNA sequencing data, traditionally incorporated both RNA and DNA sequencing into its xT broad-panel assay. Currently, customers are provided with the versatility to place orders for each test individually or at the same time, with a possibility to add certain Tempus algorithmic tests to xR. Tailored for doctors with a specialized interest in RNA fusions or altered splicing, as well as providers, researchers, and biopharma companies demanding in-depth RNA sequencing analysis of their present samples.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/rna-sequencing-services-global-market-report

Which Is The Largest Region In The RNA Sequencing Services Market?
North America was the largest region in the RNA sequencing services market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the RNA sequencing services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the RNA Sequencing Services Market?
2. What is the CAGR expected in the RNA Sequencing Services Market?
3. What Are the Key Innovations Transforming the RNA Sequencing Services Industry?
4. Which Region Is Leading the RNA Sequencing Services Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.